Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO, Director | Common Stock | 467K | $479M | $1,025.27 | Jun 11, 2024 | Direct |
REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO, Director | Common Stock | 158K | $162M | $1,025.27 | Jun 11, 2024 | 2023 GRAT |
REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO, Director | Common Stock | 40K | $40.6M | $1,016.62 | Jun 12, 2024 | By Trust |
REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO, Director | Common Stock | 5.93K | $6.08M | $1,025.27 | Jun 11, 2024 | By 401(k) Plan |
REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO, Director | Common Stock | 0 | $0 | $1,025.27 | Jun 12, 2024 | by Trust for Son |
REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO, Director | Class A Stock | 1.71M | Jun 11, 2024 | Direct | ||
REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO, Director | Class A Stock | 14.8K | Jun 12, 2024 | by Trust for Son | ||
REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO, Director | 2019 Performance Stock Units | 0 | $844.09 | Dec 11, 2023 | Direct | |
REGENERON PHARMACEUTICALS, INC. | Bd. Co-Chair, President & CEO, Director | Non-Qualified Stock Option (right to buy) | 0 | May 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
REGN | REGENERON PHARMACEUTICALS, INC. | Jun 11, 2024 | 7 | -$25.6M | 4 | Jun 13, 2024 | Bd. Co-Chair, President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Jun 6, 2024 | 1 | -$799K | 4 | Jun 10, 2024 | Bd. Co-Chair, President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | May 17, 2024 | 2 | -$22.4M | 4 | May 17, 2024 | Bd. Co-Chair, President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | May 13, 2024 | 15 | -$95.1M | 4 | May 15, 2024 | Bd. Co-Chair, President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Dec 11, 2023 | 3 | -$10.8M | 4 | Dec 13, 2023 | Bd. Co-Chair, President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | May 15, 2023 | 2 | $0 | 4 | May 17, 2023 | President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Apr 5, 2022 | 2 | -$5.05M | 4 | Apr 7, 2022 | President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Mar 31, 2022 | 1 | -$2.05M | 4 | Apr 4, 2022 | President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Nov 19, 2021 | 6 | -$119M | 4 | Nov 19, 2021 | President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Aug 18, 2021 | 2 | -$137M | 4 | Aug 20, 2021 | President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Aug 16, 2021 | 15 | -$6.24M | 4 | Aug 17, 2021 | President & CEO, Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Aug 6, 2021 | 8 | -$118M | 4 | Aug 10, 2021 | President & CEO, Director |